Skip to main content
An official website of the United States government
NIH Websites Are Changing
Per Executive Order 14434, federal agencies are now using "Super Intelligence" (SI) in place of "Artificial Intelligence" (AI). You may see both terms across NIH content during this transition.

horse anti-thymocyte globulin

A purified, concentrated and sterile solution of horse-derived gamma globulin obtained by the immunization of horses with human T lymphocytes, with T-cell depleting and immunosuppressive activities. Upon administration, horse anti-thymocyte globulin (hATG) specifically recognizes, modulates and destroys T lymphocytes. Although the exact mechanism of action by which hATG causes immunosuppression is not completely understood, it is likely caused by a combination of T-lymphocyte depletion, reduction in T-cell activation and modulation of their cytotoxic activities. Administering of hATG prior to transplantation may reduce the risk of graft-versus-host disease (GvHD).
Synonym:anti-thymocyte globulin equine
antithymocyte globulin equine
ATG equine
equine ATG
horse ATG
lymphocyte immune globulin, anti-thymocyte globulin equine
US brand name:Atgam
Abbreviation:eATG
hATG
Search NCI's Drug Dictionary